Emerging Biopharma

Biotechs forced to learn new patent tricks to protect pipelines

A new era of global competition means strong patents, longer stealth periods and misdirection can be required to ensure drug developers retain an edge

Will Maddox Jul 12, 2026 12:00pm

Worker bees in hive seen through honeycomb

Beeline bolsters autoimmune ambitions with $126M

Jun 30, 2026 7:00am

Merck KGaA pledges $50M to new biotech with eye to acquisition

Jun 23, 2026 10:16am

With $30M, Oorja Bio breathes new life into fibrosis candidate

May 20, 2026 10:31am

Nominations now open for Fierce Biotech's 2026 Fierce 15

May 18, 2026 9:44am

Oryon shines out of stealth with $21M to fight Parkinson's

Mar 23, 2026 5:00am

More News

R1 debuts with $77.5M to advance kidney disease treatment

Mar 17, 2026 7:00am

Biotech unit Pfizer Ignite flames out

Mar 12, 2026 3:58pm

French biotech pens $128M deal for Kezar protein degrader work

Mar 12, 2026 9:00am

Atrium arises from Avidity buyout with $270M, preclinical assets

Feb 27, 2026 11:05am

See more stories